Hydroxycut products recalled due to liver injuries:  Iovate Health Sciences recalls several Hydroxycut products after FDA issues a consumer warning to discontinue use due to liver damage.  ------  Genentech pulls Raptiva from US market:  Genentech pulls the psoriasis drug Raptiva from the US market after links to a fatal brain infection  ------  Wyeth Pharmaceuticals loses Supreme Court case:  Supreme Court rules that federal labeling laws do not preempt a drug firm from being sued

Byetta Alert

 

Byetta
Byetta Side Effects Byetta Lawsuits  

 


FDA Byetta Alert   >> read more

Deaths reported with Byetta
  >> read article

Byetta (exenatide) manufactured and marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. is an injectable drug used by more than 700,000 patients with type 2 diabetes since its launch in June 2005. Byetta is in a class of drugs called incretin mimetics. Designed to induce the same effects as a blood sugar-improving hormone called GLP-1, incretin mimetics imitate the glucagon-like peptide 1 (GLP-1), a hormone that is a key regulator of blood sugar. GLP-1 class drugs stimulate the release of insulin only when glucose levels become too high.

Byetta Warning

In August 2008, the FDA announced that pancreatitis-related injuries and deaths continue to rise as a result of Byetta (http://www.fda.gov/Cder/drug/InfoSheets/HCP/exenatide2008HCP.htm). The first FDA advisory related to Byetta was issued in September 2007. The warning followed an announcement in October 2007 alerting patients and doctors to approximately 30 reports of patients suffering severe Byetta side effects such as pancreatitis. The FDA has received information on an additional six adverse reactions since the October 2007 announcement. Of those six patients, two died.

Acute pancreatitis is the swelling of the pancreas that can result in nausea, vomiting and severe abdominal pain.  Although dependent of the severity of the pancreatitis, treatment requires hospitalization with pain management and fluid and electrolyte stabilization. In severe cases, treatment may require surgery or other invasive measures.  If you are currently taking Byetta and are concerned about your health, you should contact your physician for additional information.
The FDA is working with Amylin and Eli Lilly to strengthen the Byetta warnings; this will likely include a black-box warning – the FDA’s strongest product warning – for Byetta-related pancreatitis.

Byetta Lawsuits

If you have used Byetta and have been hospitalized with pancreatitis, you need to consult with experienced consumer attorneys who specialize in medical product and defective drug liability. For more information about Byetta lawsuits, contact Levin, Simes, Kaiser & Gornick toll free at 1-877-LSKG-LAW.

To submit an on-line inquiry regarding Byetta, please fill out the form below.

 

    * required fields  
  Name*:  
 
  Email*:  
 
  Phone:  
 
  Address:  
 
  City/State/Zip  
 
  Questions or Comments:  
 
Don't enter anything here:  
     
 

 

 

 

*indicates required field





Don't enter anything here:  

 

 

Levin Simes Kaiser & Gornick, LLP
44 Montgomery Street, 36th floor
San Francisco, CA 94104

Ph: 1-877-LSKG-LAW
     (1-877-575-4529)
Fax: 415-981-1270

 

 

 

 

Home | About Us | Our Results | Defective Drugs | Mesothelioma | Medical Devices | Consumer Class Actions | Contact Us

© 2007 Levin Simes Kaiser & Gornick
Web Marketing Powered by TCGLaw Group